OverviewChartNewsTraderScreen

HSBC Call 220 22UA 14.01.2026/  DE000HG81E45  /

EUWAX
2024-05-16  12:30:14 PM Chg.-0.007 Bid12:36:59 PM Ask12:36:59 PM Underlying Strike price Expiration date Option type
0.101EUR -6.48% 0.104
Bid Size: 150,000		 0.134
Ask Size: 150,000		 BIONTECH SE SPON. AD... 220.00 - 2026-01-14 Call
TeleTrader 05-06 BioNTech's Q1 revenue slumps 85% to €187.6M
GlobeNewswire 05-06 BioNTech Announces First Quarter 2024 Financial Results and Corporate Update
GlobeNewswire 04-22 BioNTech to Report First Quarter 2024 Financial Results and Corporate Update on May 6, 2024
GlobeNewswire 04-07 Three-year Phase 1 Follow-Up Data for mRNA-based Individualized Immunotherapy Candidate Show Persis...
TeleTrader 03-20 BioNTech Q4 revenue plunges 65% to €1.48B
GlobeNewswire 03-20 BioNTech Announces Fourth Quarter and Full Year 2023 Financial Results and Corporate Update
GlobeNewswire 03-20 BioNTech Announces Appointment of Annemarie Hanekamp to Management Board as Chief Commercial Officer
GlobeNewswire 03-11 BioNTech to Present Clinical Data Updates for Personalized mRNA-based and Targeted Oncology Candidat...
GlobeNewswire 03-07 BioNTech Announces Planned Retirement of Sean Marett
GlobeNewswire 03-06 BioNTech to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update ...
GlobeNewswire 02-08 BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Exp...
GlobeNewswire 01-31 BioNTech and DualityBio Receive FDA Fast Track Designation for Next-Generation Antibody-Drug Conjuga...
GlobeNewswire 01-22 BioNTech and DualityBio Initiate Pivotal Phase 3 Trial Of Antibody-Drug Conjugate Candidate BNT323/...
TeleTrader 01-09 BioNTech sees $3.3B revenue for 2024, expanding into oncology
GlobeNewswire 01-09 BioNTech Outlines 2024 Strategic Priorities at the 42nd Annual J.P. Morgan Healthcare Conference
GlobeNewswire 2023-12-21 BioNTech and DualityBio Receive FDA Breakthrough Therapy Designation for Antibody-Drug Conjugate Can...
GlobeNewswire 2023-12-18 BioNTech Achieves Milestone at mRNA-based Vaccine Manufacturing Site in Rwanda
GlobeNewswire 2023-12-12 BioNTech to Inaugurate First African Site on December 18, 2023
TeleTrader 2023-11-06 BioNTech Q3 revenue plummets 74% to €895M
GlobeNewswire 2023-11-06 BioNTech Announces Third Quarter 2023 Financial Results and Corporate Update
GlobeNewswire 2023-10-26 Pfizer and BioNTech Announce Positive Topline Data for mRNA-based Combination Vaccine Program Agains...
GlobeNewswire 2023-10-23 BioNTech Presents Positive Phase 1/2 Data Update for CAR-T Cell Therapy Candidate BNT211 in Advance...
GlobeNewswire 2023-10-23 BioNTech to Report Third Quarter Financial Results and Corporate Update on November 6, 2023, And to ...
GlobeNewswire 2023-10-19 BioNTech Expands Late-Stage Clinical Oncology Portfolio with Initiation of further Phase 2 Trial wit...
GlobeNewswire 2023-10-16 BioNTech to Present Multiple Program Updates Across Modalities at ESMO Congress 2023